Comparing the efficiency of topical paromomycin with intralesional meglumine antimoniate for cutaneous leishmaniasis
- 23 December 2004
- journal article
- Published by Wiley in International Journal of Dermatology
- Vol. 44 (12) , 1064-1065
- https://doi.org/10.1111/j.1365-4632.2004.02597.x
Abstract
No abstract availableKeywords
This publication has 6 references indexed in Scilit:
- Treatment of cutaneous leishmaniasis with either topical paromomycin or intralesional meglumine antimoniateClinical and Experimental Dermatology, 2003
- Treatment of cutaneous leishmaniasis with 20% paromomycin ointmentJournal of the European Academy of Dermatology and Venereology, 1999
- Treatment of cutaneous leishmaniasis with 20% paromomycin ointmentJournal of the European Academy of Dermatology and Venereology, 1999
- Weekly versus every 3 days intralesional meglumine antimoniate therapy for cutaneous leishmaniasisJournal of Dermatological Treatment, 1998
- Topical treatment of Old World cutaneous leishmaniasis caused by Leishmania major: A double-blind control studyJournal of the American Academy of Dermatology, 1992
- Topical Treatment of Cutaneous LeishmaniasisJournal of Investigative Dermatology, 1986